摘要：

Reports on the selective inhibition of ras-dependent transformation by a farnesyltransferase inhibitor in cells. Farnesylation of the cysteine residue located in a carboxyl-terminal tetrapeptide; Anticancer agents for tumors in which Ras contribures to transformation.

展开